Yahoo Web Search

Search results

1. • Aptevo Therapeutics Announces Pricing of $4.6 Million Public Offering

     Morningstar· 2 weeks ago

     (NASDAQ:APVO), a clinical-stage biotechnology company focused on developing novel immune-oncology therapeutics based on its proprietary ADAPTIR™ and ADAPTIR-FLEX ...

2. • COVID-19: Notable Impacts for Post-Acute Providers from the CARES Act, CMS Blanket Waivers, and the...

     The National Law Review· 1 week ago

     Between various blanket Section 1135 waivers and state specific waivers issued by CMS, provisions of the Coronavirus Aid, Relief, and ...

3. • XORTX Announces Publication of Key Research in ADPKD

     Morningstar· 3 days ago

     ...Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANUA WKN: A3UNZ), a late-stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, is pleased to announce a research paper titled “Raising serum uric acid with a uricase inhibitor worsens...

4. • 

     Pets pass antibiotic-resistant 'superbugs' to humans

     UPI· 1 week ago

     Cases of these "superbugs" being passed between sick dogs and cats and their healthy owners have been identified in the U.K. and Portugal ...